MedPath

The Clinical Trial for Primary Chronic Venous Insufficiency

Not Applicable
Conditions
Primary Chronic Venous Insufficiency
Registration Number
NCT00931424
Lead Sponsor
Sun Yat-sen University
Brief Summary

A multicenter Random Clinical Trial to confirm the advantage of the valve reconstructive surgery on Primary Chronic Venous Insufficiency.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • PCVI patients with III degree back flow in deep vein that is confirmed by color doppler or phlebography
Exclusion Criteria
  • age over 70 years old
  • pregnancy
  • patients with severity arteriosclerosis obliterans, malignancy, severity disease of heart, lung or brain, and hematopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
clinical-etiology-anatomic-pathophysiologic classification system3 month, 1 year, 3 year, 5 year, 7 year
Secondary Outcome Measures
NameTimeMethod
color doppler3 month, 1 year, 3 year, 5 year, 7 year
phlebography3 month, 1 year, 3 year, 5 year, 7 year

Trial Locations

Locations (1)

The first affiliated hospital of Sun Yat-Sen University

🇨🇳

Guang Zhou, Guang dong, China

The first affiliated hospital of Sun Yat-Sen University
🇨🇳Guang Zhou, Guang dong, China
Shen-ming Wang, Doctor
Contact
+86 020 87755766-8198
shenmingwang@sohu.com
Shen-ming Wang, professor
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.